Literature DB >> 2478476

Isolation, purification, and characterization of fragment B, the NH2-terminal half of the heavy chain of tetanus toxin.

M Matsuda1, D L Lei, N Sugimoto, K Ozutsumi, T Okabe.   

Abstract

Fragment B, the N-terminal half of the heavy chain, an important domain of the tetanus neurotoxin molecule, was isolated for the first time. Tetanus toxin (composed of three domains, A, B, and C) was prepared from culture filtrates. Fragment A-B, derived from the toxin treated mildly with papain, was used for the isolation of fragment B. Fragment A-B obtained was dissociated into fragments A and B by reduction with 100 mM dithiothreitol and treatment with 2 M urea. Fragment B was separated from fragment A by ion-exchange column chromatography on a Mono Q column equilibrated with 20 mM Tris hydrochloride buffer (pH 7.6), containing 1 mM dithiothreitol and 2 M urea, in a fast-protein liquid chromatography system by elution with a linear gradient of 0 to 0.5 M NaCl. Fragment B was obtained in two forms having molecular weights of 48,000 +/- 2,000, which were indistinguishable by sodium dodecyl sulfate-gel electrophoresis or antigenic specificity, but distinguishable on polyacrylamide gel electrophoresis without sodium dodecyl sulfate and on isoelectric focusing (pI 6.7 and 7.3). The recovery of fragment B was 50 to 72% of that of fragment A-B on a molar basis. Purified fragment B was not toxic to mice on intravenous or intramuscular injection at doses of up to 100 micrograms, but was found to form channels (ca. 2.3 pS) in a lipid bilayer membrane by a patch clamp technique. The role of domain B of the tetanus toxin molecule in the mechanism of action of the toxin is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478476      PMCID: PMC259872          DOI: 10.1128/iai.57.11.3588-3593.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  AN APPARATUS FOR PREPARATIVE TEMPERATURE-REGULATED POLYACRYLAMIDE GEL ELECTROPHORESIS.

Authors:  T JOVIN; A CHRAMBACH; M A NAUGHTON
Journal:  Anal Biochem       Date:  1964-11       Impact factor: 3.365

2.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

3.  Papain-derived fragment IIc of tetanus toxin: its binding to isolated synaptic membranes and retrograde axonal transport.

Authors:  B Bizzini; P Grob; K Akert
Journal:  Brain Res       Date:  1981-04-06       Impact factor: 3.252

4.  Structure of tetanus toxin. II. Toxin binding to ganglioside.

Authors:  T B Helting; O Zwisler; H Wiegandt
Journal:  J Biol Chem       Date:  1977-01-10       Impact factor: 5.157

5.  An antigenic polypeptide fragment isolated from tetanus toxin: chemical characterization, binding to gangliosides and retrograde axonal transport in various neuron systems.

Authors:  B Bizzini; K Stoeckel; M Schwab
Journal:  J Neurochem       Date:  1977-03       Impact factor: 5.372

6.  Tetanus toxin fragment forms channels in lipid vesicles at low pH.

Authors:  P Boquet; E Duflot
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

7.  Antigenic substructure of tetanus neurotoxin.

Authors:  M Matsuda; M Yoneda
Journal:  Biochem Biophys Res Commun       Date:  1977-07-11       Impact factor: 3.575

8.  Acute botulinum-like intoxication by tetanus neurotoxin in mice.

Authors:  M Matsuda; N Sugimoto; K Ozutsumi; T Hirai
Journal:  Biochem Biophys Res Commun       Date:  1982-01-29       Impact factor: 3.575

9.  Reconstitution of tetanus neurotoxin from two antigenically active polypeptide fragments.

Authors:  M Matsuda; M Yoneda
Journal:  Biochem Biophys Res Commun       Date:  1976-02-09       Impact factor: 3.575

10.  Blocking effects of tetanus toxin and its fragment [A-B] on the excitatory and inhibitory synapses of the spinal motoneurone of the cat.

Authors:  K Takano; F Kirchner; A Gremmelt; M Matsuda; N Ozutsumi; N Sugimoto
Journal:  Toxicon       Date:  1989       Impact factor: 3.033

View more
  3 in total

1.  Characteristics of toxin-neutralization by anti-tetanus human monoclonal antibodies directed against the three functional domains [A], [B] and [C] of the tetanus toxin molecule and a reliable method for evaluating the protective effects of monoclonal antibodies.

Authors:  M Matsuda; M Kamei; N Sugimoto; Y Ma; S Hashizume
Journal:  Eur J Epidemiol       Date:  1992-01       Impact factor: 8.082

2.  Pathogen-inspired drug delivery to the central nervous system.

Authors:  Rebecca L McCall; Joseph Cacaccio; Eileen Wrabel; Mary E Schwartz; Timothy P Coleman; Rachael W Sirianni
Journal:  Tissue Barriers       Date:  2014-08-08

Review 3.  Tetanus Toxin Fragment C: Structure, Drug Discovery Research and Production.

Authors:  Caroline Bayart; Angélique Mularoni; Nada Hemmani; Soumeya Kerachni; Joachim Jose; Patrice Gouet; Joseph Paladino; Marc Le Borgne
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.